KLF4 is of particular interest because of its reported role in promoting EndoMT in several vascular diseases, including cerebral cavernous malformations (22, 34), coronary arterial wall damage in Kawasaki disease (35), and tumor vascular dysfunction (36). This evidence concerns the gene KLF4 and cerebral cavernous malformation.